Literature DB >> 8384817

Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.

N H Georgopapadakou1, A Bertasso.   

Abstract

Cephalosporin 3'-quinolone esters, carbamates, and tertiary amines are potent antibiotics whose antibacterial activities reflect the action of both the beta-lactam and the quinolone components. The biological properties of representative compounds from each class were compared in Escherichia coli. All compounds bound to the essential PBP 3, inhibited DNA gyrase, and caused filamentation in growing cells. To distinguish between cephalosporin- and quinolone-induced filaments, nucleoid segregation was also examined, as quinolones disrupt nucleoid segregation while the beta-lactams do not (N. H. Georgopapadakou and A. Bertasso, Antimicrob. Agents Chemother. 35:2645-2648, 1991). The cephalosporin quinolone esters Ro 23-9424 and Ro 24-6392, at concentrations causing filamentation in E. coli ATCC 25922, did not affect nucleoid segregation after 1 h of incubation (cephalosporin response) but did not affect it after 2 h (quinolone response), indicating the release of free quinolone. Accordingly, only the quinolone response was produced in a strain possessing TEM-3, an expanded-spectrum beta-lactamase. The cephalosporin carbamate Ro 24-4383 and the tertiary amine Ro 24-8138 produced a quinolone response in E. coli ATCC 25922, though they produced a cephalosporin response in a quinolone-resistant strain. Carbamate and tertiary amine linkages are chemically more stable than the ester linkage, and both cephalosporin 3'-quinolone carbamates and tertiary amines are more potent inhibitors of DNA gyrase than are the corresponding esters. The results suggest that, while intact cephalosporin 3'-quinolone esters act as cephalosporins, carbamates and amines may possess both cephalosporin and quinolone activity in the intact molecule.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384817      PMCID: PMC187707          DOI: 10.1128/AAC.37.3.559

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

Review 1.  DNA topoisomerases.

Authors:  M Gellert
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 2.  The SOS regulatory system of Escherichia coli.

Authors:  J W Little; D W Mount
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

3.  Peptidoglycan synthetic enzyme activities of highly purified penicillin-binding protein 3 in Escherichia coli: a septum-forming reaction sequence.

Authors:  F Ishino; M Matsuhashi
Journal:  Biochem Biophys Res Commun       Date:  1981-08-14       Impact factor: 3.575

4.  Studies on the mode of action of nalidixic acid.

Authors:  A M Pedrini; D Geroldi; A Siccardi; A Falaschi
Journal:  Eur J Biochem       Date:  1972-02-15

5.  Replication and repair of DNA in cells of Escherichia coli treated with toluene.

Authors:  R E Moses; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

6.  Bacterial chromosome segregation: evidence for DNA gyrase involvement in decatenation.

Authors:  T R Steck; K Drlica
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

7.  Interactions of 4', 6-diamidine-2-phenylindole with synthetic polynucleotides.

Authors:  J Kapuściński; W Szer
Journal:  Nucleic Acids Res       Date:  1979-08-10       Impact factor: 16.971

8.  Interaction of diamidino-2-phenylindole (DAPI) with natural and synthetic nucleic acids.

Authors:  G Manzini; M L Barcellona; M Avitabile; F Quadrifoglio
Journal:  Nucleic Acids Res       Date:  1983-12-20       Impact factor: 16.971

9.  Indirect method for assessing the penetration of beta-lactamase-nonsusceptible penicillins and cephalosporins in Escherichia coli strains.

Authors:  M H Richmond; D C Clark; S Wotton
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

10.  Penicillin-binding proteins in bacteria.

Authors:  N H Georgopapadakou; F Y Liu
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

View more
  7 in total

1.  Structure-activity studies of quinolone-penems in genetically defined strains of Escherichia coli.

Authors:  A F Ehrhardt; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 2.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

3.  Low-level resistance to the cephalosporin 3'-quinolone ester Ro 23-9424 in Escherichia coli.

Authors:  J S Chapman; A Bertasso; L M Cummings; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

4.  Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.

Authors:  Geoffrey W Stone; Qin Zhang; Rosario Castillo; V Ramana Doppalapudi; Analia R Bueno; Jean Y Lee; Qing Li; Maria Sergeeva; Gody Khambatta; Nafsika H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

5.  beta-Lactamase hydrolysis of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines.

Authors:  N H Georgopapadakou; C McCaffrey
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

6.  A conventional HPLC-MS method for the simultaneous determination of ofloxacin and cefixime in plasma: Development and validation.

Authors:  Mahesh V Attimarad; Ahmed O Alnajjar
Journal:  J Basic Clin Pharm       Date:  2013-03

7.  Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptor.

Authors:  Sulochana Somasundaram; Ramaian Santhaseela Anand; Perumal Venkatesan; Chinnambedu N Paramasivan
Journal:  BMC Microbiol       Date:  2013-10-01       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.